多维度决策分析在血友病预防性治疗中的应用

发布时间：2018-02-26 23:15

本文关键词： 血友病预防性治疗多维度决策分析方法　出处：《中国卫生经济》2017年09期 　论文类型：期刊论文

【摘要】：目的:比较影响血友病A治疗的主要疗效因素,评价不同治疗方案的优缺点,进而为治疗方案的决策提供参考。方法:采用多维度决策分析方法 (MDCA),通过组织专家组会议,对反映血友病治疗效果的10个特性因素及其标准剂量的预防治疗、中低剂量预防治疗和按需治疗这三种治疗方案进行评分;并获得不同特性指标的权重。结果:普遍认为标准预防治疗方案最好;对费用分析后发现,标准剂量的预防治疗费用高(34.5万元),但治疗效果远好于中低剂量预防治疗和按需治疗方案。结论:从长期的成本效果分析来看,预防性治疗可以减少并发症的发生,并且降低终生的医疗成本。但目前我国各地对血凝8因子医保报销政策不同,而且补偿水平不一,急需进一步提高。
[Abstract]:Objective: to compare the main factors affecting the therapeutic effect of hemophilia A, evaluate the advantages and disadvantages of different treatment schemes, and provide reference for the decision of treatment regimen. Methods: the expert group meeting was organized by using the method of multi-dimensional decision analysis (MDCAA). Ten characteristic factors and their standard dose prophylaxis therapy, middle and low dose prophylaxis therapy and on-demand treatment were evaluated. The weight of different characteristic indicators was obtained. Results: standard prophylaxis was generally considered to be the best; cost analysis showed that, The cost of standard dose prophylaxis is high (345,000 yuan), but the therapeutic effect is much better than that of low-dose preventive therapy and on-demand treatment. Conclusion: from the long-term cost-effect analysis, prophylactic treatment can reduce the incidence of complications. But at present, the reimbursement policy of hemagglutination 8 factor medical insurance is different in our country, and the compensation level is different, so it needs to be further improved.
【作者单位】：复旦大学公共卫生学院;上海市医学科学技术情报研究所(上海市卫生发展研究中心)卫生政策研究部;
【分类号】：R554.1

【相似文献】